T. Rowe Price Associates’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $197M | Sell |
|
|||||
|
2025
Q1 | $277M | Buy |
|
|||||
|
2024
Q4 | $324M | Buy |
|
|||||
|
2024
Q3 | $225M | Buy |
|
|||||
|
2024
Q2 | $50.1M | Sell |
|
|||||
|
2024
Q1 | $92.9M | Sell |
|
|||||
|
2023
Q4 | $107M | Sell |
|
|||||
|
2023
Q3 | $115M | Sell |
|
|||||
|
2023
Q2 | $205M | Buy |
|
|||||
|
2023
Q1 | $121M | Sell |
|
|||||
|
2022
Q4 | $247M | Sell |
|
|||||
|
2022
Q3 | $189M | Sell |
|
|||||
|
2022
Q2 | $607M | Sell |
|
|||||
|
2022
Q1 | $1.34B | Buy |
|
|||||
|
2021
Q4 | $1.07B | Sell |
|
|||||
|
2021
Q3 | $1.77B | Sell |
|
|||||
|
2021
Q2 | $2.46B | Buy |
|
|||||
|
2021
Q1 | $2.41B | Buy |
|
|||||
|
2020
Q4 | $2.19B | Sell |
|
|||||
|
2020
Q3 | $2.04B | Sell |
|
|||||
|
2020
Q2 | $1.86B | Sell |
|
|||||
|
2020
Q1 | $1.26B | Buy |
|
|||||
|
2019
Q4 | $1.73B | Buy |
|
|||||
|
2019
Q3 | $1.05B | Buy |
|
|||||
|
2019
Q2 | $848M | Sell |
|
|||||
|
2019
Q1 | $718M | Sell |
|
|||||
|
2018
Q4 | $622M | Sell |
|
|||||
|
2018
Q3 | $860M | Buy |
|
|||||
|
2018
Q2 | $395M | Buy |
|
|||||
|
2018
Q1 | $2.02M | Buy |
|
|||||
|
2017
Q4 | $1.96M | Buy |
|
|||||
|
2017
Q3 | $1.76M | Buy |
|
|||||
|
2017
Q2 | $1.32M | Sell |
|
|||||
|
2017
Q1 | $5.59M | Sell |
|
|||||
|
2016
Q4 | $3.19M | Sell |
|
|||||
|
2016
Q3 | $4.88M | Buy |
|
|||||
|
2016
Q2 | $3.15M | Buy |
|
|||||
|
2016
Q1 | $1.59M | Sell |
|
|||||
|
2015
Q4 | $5.01M | Buy |
|
|||||
|
2015
Q3 | $8.94M | Sell |
|
|||||
|
2015
Q2 | $15.2M | Buy |
|
|||||
|
2015
Q1 | $11M | Buy |
|
|||||
|
2014
Q4 | $13.7M | Buy |
|
|||||
|
2014
Q3 | $8.08M | Sell |
|
|||||
|
2014
Q2 | $12.4M | Buy |
|
|||||
|
2014
Q1 | $400K | Sell |
|
|||||
|
2013
Q4 | $430K | Buy |
|